Knockout Tested Rabbit Polyclonal RNF31/HOIP antibody. Suitable for IP, WB and reacts with Human samples. Cited in 12 publications. Immunogen corresponding to Synthetic Peptide within Human RNF31 aa 1000 to C-terminus.
View Alternative Names
ZIBRA, RNF31, E3 ubiquitin-protein ligase RNF31, HOIL-1-interacting protein, RING finger protein 31, RING-type E3 ubiquitin transferase RNF31, Zinc in-between-RING-finger ubiquitin-associated domain protein, HOIP
- IP
Supplier Data
Immunoprecipitation - Anti-RNF31/HOIP antibody (AB125189)
Detection of human RNF31/HOIP by western blot of immunoprecipitates. Samples : Whole cell lysate (0.5 or 1.0 mg per IP reaction; 20% of IP loaded) from HeLa cells prepared using NETN lysis buffer. Antibodies : Affinity purified rabbit anti-RNF31/HOIP antibody ab125189 used for IP at 6 μg per reaction. RNF31/HOIP was also immunoprecipitated by a previous lot of this antibody. For blotting immunoprecipitated RNF31/HOIP, ab125189 was used at 1 μg/mL. Detection : Chemiluminescence with an exposure time of 3 minutes.
All lanes:
Immunoprecipitation - Anti-RNF31/HOIP antibody (ab125189)
Predicted band size: 120 kDa
false
- WB
Lab
Western blot - Anti-RNF31/HOIP antibody (AB125189)
Western blot : Anti-RNF31 antibody (ab125189) staining at 1/3000 dilution, shown in green; Mouse anti-CANX [CANX/1543] (ab238078) loading control staining at 1/20000 dilution, shown in magenta. In Western blot, ab125189 was shown to bind specifically to RNF31. A band was observed at 130-140 kDa in wild-type A549 cell lysates with no signal observed at this size in RNF31 knockout cell line. To generate this image, wild-type and RNF31 knockout A549 cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution.
All lanes:
Western blot - Anti-RNF31/HOIP antibody (ab125189) at 1/3000 dilution
Lane 1:
Wild-type A549 cell lysate at 20 µg
Lane 2:
RNF31 knockout A549 cell lysate at 20 µg
Lane 3:
HeLa cell lysate at 20 µg
Lane 4:
HepG2 cell lysate at 20 µg
Secondary
All lanes:
Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution
false
- WB
Lab
Western blot - Anti-RNF31/HOIP antibody (AB125189)
Western blot : Anti-RNF31 antibody (ab125189) staining at 1/1000 dilution, shown in green; Mouse anti-CANX [CANX/1543] (ab238078) loading control staining at 1/20000 dilution, shown in magenta. In Western blot, ab125189 was shown to bind specifically to RNF31. A band was observed at 130 kDa in wild-type A549 cell lysates with no signal observed at this size in RNF31 knockout cell line. To generate this image, wild-type and RNF31 knockout A549 cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution.
All lanes:
Western blot - Anti-RNF31/HOIP antibody (ab125189) at 1/1000 dilution
Lane 1:
Wild-type A549 cell lysate at 20 µg
Lane 2:
RNF31 knockout A549 cell lysate at 20 µg
Lane 3:
HeLa cell lysate at 20 µg
Lane 4:
HepG2 cell lysate at 20 µg
Secondary
All lanes:
Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution
Predicted band size: 120 kDa
Observed band size: 130 kDa
false
- WB
Unknown
Western blot - Anti-RNF31/HOIP antibody (AB125189)
All lanes:
Western blot - Anti-RNF31/HOIP antibody (ab125189) at 0.4 µg/mL
Lane 1:
HeLa whole cell lysate at 50 µg
Lane 2:
HeLa whole cell lysate at 15 µg
Lane 3:
293T whole cell lysate at 50 µg
Lane 4:
Jurkat whole cell lysate at 50 µg
Predicted band size: 120 kDa
true
Exposure time: 3min
Reactivity data
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
RNF31/HOIP plays an important role in immune response regulation. It functions as part of the LUBAC complex alongside SHARPIN and RBCK1 (also known as HOIL-1L) which together catalyze the linear ubiquitination of substrates. These modifications regulate NF-kB signaling which is an important pathway involved in immune and inflammatory responses. RNF31's ubiquitin ligase activity adds linear ubiquitin chains to target proteins influencing their stability and function therefore impacting the immune cell function and survival.
Pathways
RNF31/HOIP integrates into the NF-kB and the apoptosis pathways. In the NF-kB pathway it acts as a regulator of cytokine production and cell survival. RNF31 achieves this through modification of NEMO (NF-kB essential modulator) an important protein in this pathway. In apoptosis regulation linear ubiquitination by RNF31 modulates the activity of proteins such as caspases preventing inappropriate cell death during immune responses. This helps to maintain balance between survival and death signals in cells allowing for proper immune function.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (12)
Recent publications for all applications. Explore the full list and refine your search
Nature communications 15:2974 PubMed38582895
2024
Applications
Unspecified application
Species
Unspecified reactive species
Disease models & mechanisms 16: PubMed37589075
2023
Applications
Unspecified application
Species
Unspecified reactive species
The FEBS journal 290:4224-4237 PubMed36779231
2023
Applications
Unspecified application
Species
Unspecified reactive species
Journal of experimental & clinical cancer research : CR 41:364 PubMed36581998
2022
Applications
Unspecified application
Species
Unspecified reactive species
Oncology letters 24:394 PubMed36276481
2022
Applications
Unspecified application
Species
Unspecified reactive species
Cells 11: PubMed35954242
2022
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in immunology 12:635475 PubMed33815386
2021
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in immunology 11:601926 PubMed33329596
2020
Applications
Unspecified application
Species
Unspecified reactive species
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 34:12751-12767 PubMed32738097
2020
Applications
Unspecified application
Species
Unspecified reactive species
Communications biology 3:163 PubMed32246052
2020
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com